The Southern California Biomedical Council (SoCalBio) – a member-supported trade association that serves biotech and medical device firms, research organizations and academic institutions throughout the Greater Los Angeles region – has announced that 22 early- to late-stage companies are confirmed to present at the 10th Annual SoCalBio Investor Conference, which will be held September 19th at the Wilshire Grand Hotel in downtown Los Angeles.
The SoCalBio Investor Conference is the only annual conference of its kind in the Los Angeles region. Companies selected to present focus on a wide range of technologies and market segments including regenerative medicine, therapeutic devices targeting neurodegenerative disorders, cardiovascular devices, cancer therapeutics, teleradiology, biosensors, and personalized medicine.
The list of confirmed companies (along with their lead product/R&D focus) includes:
Active Life Technologies (Santa Barbara, CA): Devices for measuring the mechanical properties of bones and other hard tissues in vivo. Adventrx (San Diego, CA): Biopharmaceutical R&D focused on proprietary therapeutic candidates for treating cancer and infectious diseases. Allvivo Vascular (Lake Forest, CA): Focused on developing a biomimetic coronary stent coating called ProteoGuard(TM) that prevents restenosis without the need for extended courses of dual antiplatelet therapy. Anergix (Los Angeles, CA): Cell therapy for neurodegenerative disorders. Bone-Rad (Irvine, CA): Radioactive bone cement for use as a cost-effective treatment paradigm for managing cancer tumors in bone. California Stem Cell (Irvine, CA): Focused on manufacturing high-purity human cells for therapeutic development and clinical applications. Capricor (Los Angeles, CA): Biotherapeutics for the treatment of heart disease. DermTech (San Diego, CA): Development and validation of molecular tests using specimens derived from skin. DxTerity Diagnostics (Rancho Dominguez, CA): DNA testing platforms that allow physicians to routinely and inexpensively test a patient's genetic make-up without requiring cumbersome and expensive enzymatic testing protocols. EOS Neuroscience (Los Angeles, CA): Optical prostheses for the treatment of neurological diseases. Histogen (San Diego, CA): Focused on regenerative medicine based on products manufactured by newborn human fibroblasts. Inscent (Irvine, CA): R&D for using insect sensory machinery to construct biosensor devices for various applications. Integrated Endoscopy (Rancho Santa Margarita, CA): New endoscope design MiCardia (Irvine, CA): Minimally invasive methods to treat heart valve disease. NeoMatrix (Irvine, CA): Devices that promote optimal breast health. Nidus Laboratories (Los Angeles, CA): Small cyclic peptides to treat immune disorders, inflammation and cancer. Organovo: Platform technology for "organ printing" that allows precise placement of cell types into structures (e.g., blood vessels and complex organs) to aid transplantation. Radlink (Torrance, CA): An innovative manufacturer of digital medical imaging for diagnostic use. Spectrum Pharmaceuticals (Irvine, CA): Acquisition, development and commercialization of a diverse portfolio of oncology drug candidates. TerraPharm: Specialized pharmaceuticals focused on prescription botanical drugs and medical foods to treat major chronic diseases. Tissue Genetics Inc. (Boulder, CO) Molecular diagnostics for breast and ovarian cancers. Wavestate (Marina del Rey, CA): Medical device technology to improve neurointensive care.
In addition to presentations by the above companies, the 10th SoCalBio Investor Conference will feature keynote presentations and breakouts that engage technologists, investors and entrepreneurs in a discussion about strategies to expedite the commercialization of life-saving medical technologies.
For a detailed agenda, please visit the Southern California Biomedical Council’s Web site at www.socalbio.org.
Conference Sponsors:
The 10th SoCalBio Investor Conference is sponsored by organizations dedicated to the growth of life-science industry in Greater Los Angeles. The list of generous supporters includes the following:
Platinum: ---------------------------------------------------------------------- Perkins Coie LLP http://www.perkinscoie.com Gold: ---------------------------------------------------------------------- Alfred Mann Institute at USC http://ami.usc.edu Ernst & Young LLP http://www.ey.com Oracle Corp. / LST http://www.oracle.com / http://www.lstechnologies.com Prism VentureWorks http://www.prismventure.com Reed Smith LLP http://www.reedsmith.com Silver: ---------------------------------------------------------------------- Bench International http://www.benchinternational.com Bingham McCutchen LLP http://www.bingham.com Bolton & Company http://www.boltonco.com Los Angeles Biomedical Research Institute http://www.labiomed.org Bronze: ---------------------------------------------------------------------- California Technology Ventures / Jacobs Capital Group http://www.ctventures.com Davis Wright Tremaine LLP http://www.dwt.com Irvine Pharmaceutical Services http://www.irvinepharma.com Los Angeles/Orange County Biotechnology Center http://www.paccd.cc.ca.us/instadmn/lifesci/biotech/ednet.htm Macadamian, Inc. http://www.macadamian.com One Lambda http://www.onelambda.com USI http://www.usi.biz
About the Southern California Biomedical Council (SoCalBio):
The Southern California Biomedical Council is a nonprofit, member-supported trade association that represents the biotech and medical device industries in the Greater Los Angeles region.
SoCalBio’s programs help local firms gain access to capital, potential partners and business support services. The annual SoCalBio Investor Conference has grown to become the region’s premier showcase for emerging life-science companies and technologies. SoCalBio also promotes technology transfer and workforce training while educating policy makers and the public at-large about the benefits of the life-science industry.
SoCalBio is open to membership by firms and organizations engaged in biotech, medical device technology development and commercialization throughout Los Angeles/Orange Counties, the Gold Coast, and Inland Empire. More information is available at www.socalbio.org.
Comments